Page last updated: 2024-10-31

mianserin and Borderline Personality Disorder

mianserin has been researched along with Borderline Personality Disorder in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Borderline Personality Disorder: A personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. (DSM-IV)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gentile, S1
Montgomery, SA1
Roy, D1
Montgomery, DB1

Trials

1 trial available for mianserin and Borderline Personality Disorder

ArticleYear
The prevention of recurrent suicidal acts.
    British journal of clinical pharmacology, 1983, Volume: 15 Suppl 2

    Topics: Adult; Borderline Personality Disorder; Depressive Disorder; Dibenzazepines; Female; Histrionic Pers

1983

Other Studies

1 other study available for mianserin and Borderline Personality Disorder

ArticleYear
Pharmacological management of borderline personality disorder in a pregnant woman with a previous history of alcohol addiction: a case report.
    Clinical drug investigation, 2015, Volume: 35, Issue:11

    Topics: Adult; Alcoholism; Borderline Personality Disorder; Diagnosis, Dual (Psychiatry); Female; Humans; Mi

2015